Dashboard
Manage Tickers

SNSESensei Biotherapeutics, Inc.

Nasdaq senseibio.com


$ 0.79 $ -0.66 (-45.52 %)    

Friday, 24-May-2024 15:30:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 4.29 (0.95 %)
DIA $ 398.57 $ -0.02 (-0.01 %)
SPY $ 530.36 $ 3.48 (0.66 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ 0.79
$ 0.88
$ 0.00 x 0
$ 0.00 x 0
$ 0.72 - $ 0.88
$ 0.51 - $ 1.94
1,408,115
na
19.79M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/27/2024 16:31:22

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/27/2024 12:05:50

why-netease-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why NetEase Shares Are Trading Lower? Here...
05/24/2024 17:57:35

hc-wainwright--co-reiterates-buy-on-sensei-biotherapeutics-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Sens...
05/24/2024 16:38:26

HC Wainwright & Co. analyst Edward White reiterates Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy and maintains $4 pri...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/24/2024 16:31:03

stephens--co-reiterates-overweight-on-sensei-biotherapeutics-maintains-5-price-target
Stephens & Co. Reiterates Overweight on Se...
05/24/2024 15:45:55

Stephens & Co. analyst Sudan Loganathan reiterates Sensei Biotherapeutics (NASDAQ:SNSE) with a Overweight and maintains ...

dow-surges-50-points-us-durable-goods-orders-increase-in-april
Dow Surges 50 Points; US Durable Goods Ord...
05/24/2024 13:43:15

why-ross-stores-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Ross Stores Shares Are Trading Higher ...
05/24/2024 12:22:48

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/24/2024 12:07:16

stephens--co-initiates-coverage-on-sensei-biotherapeutics-with-overweight-rating-announces-price-target-of-5
Stephens & Co. Initiates Coverage On Sense...
05/14/2024 09:48:39

Stephens & Co. analyst Sudan Loganathan initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Overweight rat...

sensei-biotherapeutics-cash-cash-equivalents-and-marketable-securities-were-581m-as-of-march-31-2024-expected-to-fund-operations-into-the-fourth-quarter-of-2025
Sensei Biotherapeutics' Cash, Cash Equival...
05/09/2024 12:36:51

sensei-biotherapeutics-q1-2024-gaap-eps-032-misses-029-estimate
Sensei Biotherapeutics Q1 2024 GAAP EPS $(...
05/09/2024 12:33:48

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

sensei-biotherapeutics-to-present-topline-clinical-data-from-the-sns-101-phase-i-dose-escalation-study-at-the-2024-asco-annual-meeting
Sensei Biotherapeutics To Present Topline ...
04/24/2024 20:52:35

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

sensei-biotherapeutics-announces-nature-communications-publication-describing-mechanism-of-action-of-sns-101-selectively-targeting-the-active-form-of-vista-within-the-tumor-microenvironment
Sensei Biotherapeutics Announces Nature Co...
04/04/2024 20:10:49

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

sensei-biotherapeutics-cfo-to-resign-all-positions-with-co-effective-april-10
Sensei Biotherapeutics CFO To Resign All P...
04/02/2024 11:48:59

-SEC Filing

sensei-biotherapeutics-fy-eps-122-up-from-158-yoy-2023-year-end-cash-cash-equivalents-and-marketable-securities-of-658m-is-expected-to-provide-cash-runway-into-fourth-quarter-of-2025
Sensei Biotherapeutics FY EPS $(1.22) Up F...
02/28/2024 12:36:08

Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(1.22) per share. This is a 22.78 percent increase over loss...

sensei-biotherapeutics-says-it-completed-sns-101-monotherapy-dose-escalation-through-15-mgkg-with-no-dose-limiting-toxicities-highlights-strong-balance-sheet-with-cash-runway-extended-into-q4-of-2025
Sensei Biotherapeutics Says It Completed S...
01/04/2024 12:43:25

hc-wainwright--co-initiates-coverage-on-sensei-biotherapeutics-with-buy-rating-announces-price-target-of-4
HC Wainwright & Co. Initiates Coverage On ...
12/04/2023 11:41:46

HC Wainwright & Co. analyst Edward White initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating an...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION